Model-Informed Drug Development Summit – What’s It About?
The Model-Informed Drug Development Summit is the first and only industry-focused strategic meeting dedicated to harnessing the real-world impact of MIDD across therapeutic areas, featuring exclusive regulator insights into the ICH M15 draft guidelines, practical case studies in Oncology, CNS, CVRM, RNA, and Immunology, and success stories from global leaders showcasing how model-informed strategies streamline decision-making, accelerate timelines, and improve clinical outcomes, making this the must-attend event to stay ahead, enable smarter decisions, and position your pipeline for faster, risk-balanced market success.
Join Your Peers to:
Decode the M15 Draft with Exclusive Regulator Insights
Hear firsthand from the experts shaping the latest draft ICH M15 guidelines, and leave with actionable clarity on what’s changing, why it matters, and how to stay ahead in a rapidly evolving regulatory landscape.
Hear Real-World Regulatory Success Stories
Go beyond theory with powerful, real-world examples of how model-informed strategies have secured approvals, so you can shape submissions that stand out and accelerate your path to market.
Advance Your Trial Design with MIDD from Day 1
Discover how leading teams are embedding MIDD at the core of their strategic planning, driving smarter decision-making, faster timelines and greater confidence in your data.
See the Impact of MIDD Across Various Therapeutic Areas
Dive into compelling case studies spanning oncology, CVRM, RNA, Immunology, CNS and beyond to understand where MIDD is transforming development and delivering measurable results.
Bridge the Communication Gap Between Modelers & Biologists
Gain practical strategies to align and build cross functional teams, making MIDD implementation seamless, collaborative and a driving force for innovation across your pipeline.
Who Will You Meet?
Join a highly engaged audience of senior decision-makers, including Directors, VPs, and C-level leaders in Pharmacometrics, Clinical Pharmacology, PK/PD, and modeling, from leading pharma and biotech companies, all actively seeking to apply Model-Informed Drug Development (MIDD) within their teams and programs, alongside top academic experts and cutting-edge solution providers.
